|
Volumn 2, Issue 7, 2006, Pages 358-359
|
Is the long-term use of systemic corticosteroids beneficial in the management of Behçet's syndrome? Commentary
|
Author keywords
Beh et's syndrome; Depot corticosteroids; Erythema nodosum; Genital ulcer; Oral ulcer
|
Indexed keywords
CALCIUM;
COLCHICINE;
CORTICOSTEROID DERIVATIVE;
CYCLOSPORIN A;
IMMUNOSUPPRESSIVE AGENT;
METHOTREXATE;
METHYLPREDNISOLONE ACETATE;
PLACEBO;
PREDNISOLONE;
VITAMIN D;
ARTHRITIS;
BEHCET DISEASE;
BONE DENSITY;
CATARACTOGENESIS;
CENTRAL NERVOUS SYSTEM DISEASE;
CLINICAL FEATURE;
CLINICAL TRIAL;
DISEASE EXACERBATION;
DRUG EFFICACY;
ERYTHEMA NODOSUM;
FOLLICULITIS;
FRACTURE;
GENITAL ULCER;
HUMAN;
INTRAOCULAR HYPERTENSION;
LONG TERM CARE;
MOUTH ULCER;
OSTEOPOROSIS;
PATIENT CARE;
PRIORITY JOURNAL;
RECURRENT DISEASE;
SHORT SURVEY;
SYMPTOMATOLOGY;
TREATMENT OUTCOME;
UVEITIS;
VITAMIN SUPPLEMENTATION;
ADOLESCENT;
ADULT;
ANTI-INFLAMMATORY AGENTS;
BEHCET SYNDROME;
DOUBLE-BLIND METHOD;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
METHYLPREDNISOLONE;
MIDDLE AGED;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 33745752108
PISSN: 17458382
EISSN: 17458390
Source Type: Journal
DOI: 10.1038/ncprheum0224 Document Type: Short Survey |
Times cited : (8)
|
References (5)
|